SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-002955
Filing Date
2024-02-02
Accepted
2024-02-02 16:17:13
Documents
18
Period of Report
2024-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20240126_8k.htm   iXBRL 8-K 36777
2 EXHIBIT 10.1 ex_619845.htm EX-10.1 116126
3 EXHIBIT 10.2 ex_619846.htm EX-10.2 119347
4 EXHIBIT 10.3 ex_619847.htm EX-10.3 112274
  Complete submission text file 0001437749-24-002955.txt   604863

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240201.xsd EX-101.SCH 3409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240201_def.xml EX-101.DEF 11424
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240201_lab.xml EX-101.LAB 15310
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240201_pre.xml EX-101.PRE 11584
19 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240126_8k_htm.xml XML 2819
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 24591659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)